Metsera

Company

Last deal

$290.M

Amount

Series A

Stage

18.04.2024

Date

2

all rounds

$290.M

Total amount

General

About Company

Metsera operates as a clinical-stage biopharmaceutical company.

founded date

2022

Number of employees

11-50

Last funding type

Series A

IPO status

Private

Description

Metsera operates as a clinical-stage biopharmaceutical company.

Contacts

location

New York, NY, USA

Website URL

https://metsera.com/

Social url